Nalaganje...

KYP-2047, an Inhibitor of Prolyl-Oligopeptidase, Reduces GlioBlastoma Proliferation through Angiogenesis and Apoptosis Modulation

SIMPLE SUMMARY: Glioblastoma (GB) is the most aggressive brain tumor characterized by necrosis, excessive proliferation, and invasiveness. Despite relevant progress in conventional treatments, the survival rate for patients with GB remains low. The present study investigated the potential effect of...

Popoln opis

Shranjeno v:

Bibliografske podrobnosti
izdano v:	Cancers (Basel)
Main Authors:	Scuderi, Sarah Adriana, Casili, Giovanna, Ardizzone, Alessio, Forte, Stefano, Colarossi, Lorenzo, Sava, Serena, Paterniti, Irene, Esposito, Emanuela, Cuzzocrea, Salvatore, Campolo, Michela
Format:	Artigo
Jezik:	Inglês
Izdano:	MDPI 2021
Teme:	Article
Online dostop:	https://ncbi.nlm.nih.gov/pmc/articles/PMC8306782/ https://ncbi.nlm.nih.gov/pubmed/34298658 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13143444
Oznake:	Označite Brez oznak, prvi označite!

KYP-2047, an Inhibitor of Prolyl-Oligopeptidase, Reduces GlioBlastoma Proliferation through Angiogenesis and Apoptosis Modulation

Podobne knjige/članki